Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price growth. Does Silicon Motion (NASDAQ: SIMO ) fit the bill? Let's take a look at what its recent results tell us about its potential for future gains.
What we're looking for
The graphs you're about to see tell Silicon Motion's story, and we'll be grading the quality of that story in several ways:
What the numbers tell you
Now, let's take a look at Silicon Motion's key statistics:
Hot Medical Stocks To Watch Right Now: TCF Financial Corporation(TCB)
TCF Financial Corporation operates as the bank holding company for TCF National Bank that provides various retail and commercial banking products and services in the United States and Canada. Its products and services include consumer, small business, and commercial deposits, as well as interest-bearing checking accounts, money market accounts, regular savings accounts, certificates of deposit, and retirement savings plans; and consumer real estate loans, commercial real estate loans, commercial business loans, and multi-purpose campus cards for colleges, as well as consumer loans for personal, family, or household purposes. The company also offers leasing and equipment finance products for various companies, inventory finance products, auto finance products, and treasury services. As of December 31, 2011, it had 434 retail banking branches, including 196 branches in Illinois, 110 in Minnesota, 53 in Michigan, 36 in Colorado, 26 in Wisconsin, 7 in Arizona, 5 in Indiana, an d 1 in South Dakota. The company was founded in 1923 and is based in Wayzata, Minnesota.
Advisors' Opinion:- [By Zacks]
Shares of TCF Financial Corporation (NYSE: TCB) have recorded a year-to-date return of 26.6%. Impressive organic growth, balance sheet repositioning and strong capital deployment activities of the company were primary factors behind the growth. However, we are not so optimistic about these positives translating into further price appreciation down the road as there will likely be significant pressure on its top line.
10 Best Quality Stocks To Own For 2015: Addus HomeCare Corporation(ADUS)
Addus HomeCare Corporation provides a range of social and medical services to individuals in the home. The company serves individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill, and disabled. It offers various health services that include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. The company?s Home and Community Services division offers assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living on a long-term, continuous basis, with an average duration of 20 months per consumer. Its Home Health Services division comprises physical, occupational, and speech therapy, as well as skilled nursing services, which are offered on a short-term, intermittent, or episodic basis to individuals recovering from an acute medical condition, with an average length of care of 80 days. The company?s payor clients include federal, state, and local government programs, such as Medicaid funded programs and Medicaid waiver programs; other state agencies and Medicare; and the Veterans Health Administration, commercial insurers, and private duty consumers. The company was formerly known as Addus Holding Corporation and changed its name to Addus HomeCare Corporation in September, 2006. Addus HomeCare Corporation was incorporated in 2006 and is headquartered in Palatine, Illinois.
Advisors' Opinion:- [By Monica Gerson]
Addus HomeCare (NASDAQ: ADUS) is projected to post its Q4 earnings at $0.25 per share on revenue of $68.07 million.
magicJack VocalTec (NASDAQ: CALL) is expected to post its Q4 earnings at $0.41 per share on revenue of $35.93 million.
10 Best Quality Stocks To Own For 2015: Pacific Drilling SA (PACD)
Pacific Drilling S.A., incorporated on March 22, 2011, is an international offshore drilling Company. The Company is a provider of ultra-deepwater drilling services to the oil and natural gas industry through the use of high-specification drilling rigs. The Company�� primary business is to contract its ultra-deepwater drilling rigs, related equipment and work crews, primarily on a dayrate basis, to drill wells for its customers. The Company is primarily focused on the ultra-deepwater market. The Company generally consider ultra-deepwater to begin at water depths of more than 7,500 feet and to extend to the maximum water depths, in which rigs are capable of drilling, which is approximately 12,000 feet.
The Company operates four drillships and has four drillships under construction, two of which are under customer contract. In connection with the Restructuring, the Company�� Predecessor was contributed to a wholly owned subsidiary of the Company by a subsidiary of Quantum Pacific International Limited.
Advisors' Opinion:- [By Ben Levisohn]
Land drillers / pressure pumpers may be approaching valuation support levels and could be triggered to consolidate if current weakness persists. The theme could nevertheless be premature in offshore drilling as larger players (Diamond Offshore Drilling (DO)/Transocean/Seadrill) are still addressing dividend concerns while smaller companies (Atwood Oceanics (ATW)/Pacific Drilling (PACD)) still trade close to replacement value.
- [By Aaron Levitt]
Management recently announced a hefty 50% hike in its quarterly dividend to 37.5 cents per share of NE stock. And with a 4.8% dividend yield, NE stock is now one of the best-paying dividend stocks in the energy sector.
Dividend Stocks To Buy #5 — Pacific Drilling (PACD)Estimated Dividend Yield: 6.5%
- [By Ben Levisohn]
On the surface, offshore drilling stocks appear inexpensive with multiples at the low end of historical ranges and many stocks trading below book values. While contrarian and deep value players are beginning to nibble, we believe the offshore floating rig companies are still in the early innings of a cyclical downturn in utilization and dayrates. After a decade of good times, the deepwater drilling rig market is facing a multiyear down-cycle. Historically, most offshore drilling cycles have been short-lived as there have usually been sudden demand shocks that tend to self correct relatively quickly. This time, it is more of a new rig supply problem compounded by a moderation in offshore spending from the suddenly ��eturn driven��multinational major oil companies. That means this down-cycle should be more drawn out than usual. Specifically, we think the downturn will take about three years to play out with average floater day-rates falling about 25% with over 60 floating rigs needing to be stacked (either warm stacked or cold stacked). More importantly for investors, we think consensus 2016 floater estimates (on average) are still about 25% too high. Put another way, earnings multiples are not as attractive as some now think, in our view. Obviously, the lower-end, older floating assets will be hit the hardest. While everyone loses in this environment, we are more comfortable in owning companies with higher-quality assets that also carry higher floater contract coverage, as we expect this to provide relative safety during this downturn. Specifically, we relatively favor Ocean Rig UDW (ORIG), Pacific Drilling (PACD), and Rowan, given their high-specification exposure. Of course, this downturn is not limited to the floater side of the offshore arena. Next week, we will detail our expectations for the timing and magnitude of the utilization and dayrate declines for the offshore jackup space.
- [By Roberto Pedone]
Pacific Drilling (PACD) is an international offshore drilling contractor committed to becoming the preferred provider of ultra-deepwater drilling services to the oil and natural gas industry through the use of high-specification rigs. This stock closed up 1% to $9.94 in Thursday's trading session.
Thursday's Range: $9.87-$10.00
52-Week Range: $8.63-$10.99
Thursday's Volume: 450,000
Three-Month Average Volume: 308,772From a technical perspective, PACD bounced modestly higher here right above its 50-day moving average of $9.67 with above-average volume. This stock has been trending sideways and consolidating for the last five months, with shares moving between $8.89 on the downside and $10.23 on the upside. Shares of PACD are now starting to trend within range of triggering a breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if PACD manages to take out some key overhead resistance levels at $10.14 to $10.23 with high volume.
Traders should now look for long-biased trades in PACD as long as it's trending above its 50-day at $9.81 and then once it sustains a move or close above those breakout levels with volume that hits near or above 308,772 shares. If that breakout triggers soon, then PACD will set up to re-test or possibly take out its next major overhead resistance levels at $10.71 to its 52-week high at $10.99. Any high-volume move above $10.99 will then put its all-time high at $11.47 within range for shares of PACD.
10 Best Quality Stocks To Own For 2015: Natural Gas(NG)
NovaGold Resources Inc., through its subsidiaries, engages in the exploration and development of mineral properties primarily in North America. The company primarily explores for gold, silver, copper, zinc, and lead ores. It holds interests in the Donlin Creek property covering 81,361 acres and the Ambler property comprising 90,614 acres located in Alaska; and the Galore Creek property comprising 293,838 acres located in northwestern British Columbia, Canada. The company was formerly known as NovaCan Mining Resources (1985) Limited and changed its name to NovaGold Resources Inc. in March 1987. NovaGold Resources Inc. was founded in 1984 and is based in Vancouver, Canada.
Advisors' Opinion:- [By Dan Caplinger]
Moreover, highly speculative miners have also done badly. NovaGold Resources (NYSEMKT: NG ) represented a $130 million investment for Paulson as of March 31, and it has lost more than 55% year-to-date as investors question whether the company will successfully get its Donlin Gold project in Alaska off the ground.
- [By Holly LaFon] ref="http://www.gurufocus.com/StockBuy.php?GuruName=John+Paulson">John Paulson bough 20, 181,818 shares of NovaGold in the first quarter of 2010 at an average of $6 per share; he added 26,200 shares in the third quarter at an average of $9 per share, and 2,746,800 in the fourth quarter at an average of $9 per share. According to GuruFocus Real Time Picks, in February he increased this holding 30.49% and now owns 29,954,818 shares or 10.8% of the company.
NovaGold Resources is a gold and copper company engaged in the exploration and development of mineral properties in Alaska and Western Canada. NovaGold has a market cap of $2.26 billion; its shares were traded at around $7.68 with and P/S ratio of 5622. NovaGold had an annual average earnings growth of 31.1% over the past 10 years.
It is not a surprise that Paulson would increase his gold holdings. He said in his 2011 investor letter that ��y gold fund will top all others.��He added:
- [By Rich Duprey]
The worst performer in the sector was NovaGold Resources (NYSEMKT: NG ) , which fell 13% yesterday as it scrambles to make sense of its Donlin Gold project in Alaska, the biggest known undeveloped gold deposit anywhere. The joint venture with Barrick has essentially been in limbo since NovaGold's partner said last year it no longer made economic sense to pursue it.
10 Best Quality Stocks To Own For 2015: Etablissements Maurel et Prom SA (MAU)
Etablissements Maurel et Prom SA is a France-based company engaged in the exploration and production of hydrocarbons (oil and gas), and in oil drilling activities. Its main activities comprise geological surveys, seismic acquisition and processing, geophysical interpretation and drilling. The Company pursues its activities mainly in Africa and Latin America, but it also has its businesses in Gabon, Senegal, Congo, Mozambique, Syria, Tanzania, Colombia, Peru, Venezuela, France and Italy. Maurel & Prom SA operates through its direct and indirect subsidiaries, including M&P Venezuela SAS, Prestoil Kouilou, Maurel & Prom Peru Holdings, Maurel & Prom Tanzanie Ltd and Panther Eureka SRL, among others. In December, 2013, the Company the acquisition of all of the shares of Caroil SAS (excluding the South American business of Caroil) from Tuscany International Drilling Inc. and has sold all of its 109,000,000 common shares of Tuscany to an entity incorporated in the Cayman Islands. Advisors' Opinion:- [By Riddhi Kharkia]
Since I have touched the topic of metrics, it is worthwhile to note that Twitter�� monthly active users (MAU) number stands at 57 million as compared to approximately 1.23 billion MAUs for Facebook. Monthly active user growth ticked up just 6% for Twitter on a sequential basis, while monthly active users fell 8% year over year. Even in terms of quarterly results, Facebook was miles ahead of Twitter, which was also a factor behind the sell-off in Twitter stock.
10 Best Quality Stocks To Own For 2015: Ballard Power Systems Inc.(BLDP)
Ballard Power Systems Inc. engages in the design, development, manufacture, sale, and service of fuel cell products for motive and stationary power applications worldwide. It offers clean energy PEM (proton exchange membrane) fuel cell stacks, modules, and complete systems. The company provides fuel cell products and services for material handling and bus, back-up power, and distributed generation applications; and fuel cell engineering solutions for various fuel cell applications. It also offers carbon-based engineered material products in the form of roll goods as woven carbon fiber textile fabrics or carbon fiber papers primarily for automotive transmissions and gas diffusion layers. Ballard Power Systems Inc., through its interests in Dantherm Power A/S develops clean energy backup power through utilization of hydrogen fuel cell technology; and Automotive Fuel Cell Cooperation Corp. develops fuel cell products for the automotive fuel cell market. The company was founde d in 1979 and is headquartered in Burnaby, Canada.
Advisors' Opinion:- [By Bryan Murphy]
Had shares of its peers and competitors performed as well, it may not even be worth bringing up. But, Plug Power Inc. (NASDAQ:PLUG) shares have done significantly better than FuelCell Energy Inc. (NASDAQ:FCEL) and Ballard Power Systems Inc. (NASDAQ:BLDP) since the end of March. And, PLUG has performed considerably better than FCEL and BLDP have since mid-August. This is more than "just a little volatility." This is a leader breaking away from the pack after a very long lull. Thing is, there's plenty more room for Plug Power to keep running.
- [By Ben Eisen]
Shares of Ballard Power Systems Inc. (BLDP) �gained 5.2% after the fuel-cell maker said it had acquired patents and patent applications from United Technologies Corp. (UTX) . The intellectual property relates to fuel cells for transportation and stationary. The patents cost Ballard 5.1 million of its shares and $2 million in cash. UTC also has a license to use the patent portfolio.
10 Best Quality Stocks To Own For 2015: Synergy Pharmaceuticals Inc (SGYP)
Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company�� lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company�� active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.
As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. As of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.
The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.
Advisors' Opinion:- [By Monica Gerson]
Breaking news
Time Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable's quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company's board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
- [By Sean Williams]
Finally, Synergy Pharmaceuticals (NASDAQ: SGYP ) may have had the wildest week of them all. Synergy's share price spiked 16% on Tuesday as an analyst at Cantor Fitzgerald raised her peak sales estimate for plecanatide, the company's midstage drug for chronic idiopathic constipation and irritable bowel syndrome with constipation, to $1.58 billion from $1.05 billion, as clinical data has been stronger than expected. However, the company didn't return the favor to shareholders by -- the very next day, mind you ��announcing a secondary offering of 16.375 million shares. The downside of clinical-stage companies is the always apparent risk of dilution. Shares have lost 25% since their Tuesday close.